skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Interactions of methoxyacetic acid with androgen receptor

Journal Article · · Toxicology and Applied Pharmacology
;  [1]
  1. Division of Cell and Molecular Biology, Department of Biology, Boston University, 5 Cummington Street, Boston, MA 02215 (United States)

Endocrine disruptive compounds (EDC) alter hormone-stimulated, nuclear receptor-dependent physiological and developmental processes by a variety of mechanisms. One recently identified mode of endocrine disruption is through hormone sensitization, where the EDC modulates intracellular signaling pathways that control nuclear receptor function, thereby regulating receptor transcriptional activity indirectly. Methoxyacetic acid (MAA), the primary, active metabolite of the industrial solvent ethylene glycol monomethyl ether and a testicular toxicant, belongs to this EDC class. Modulation of nuclear receptor activity by MAA could contribute to the testicular toxicity associated with MAA exposure. In the present study, we evaluated the impact of MAA on the transcriptional activity of several nuclear receptors including the androgen receptor (AR), which plays a pivotal role in the development and maturation of spermatocytes. AR transcriptional activity is shown to be increased by MAA through a tyrosine kinase signaling pathway that involves PI3-kinase. In a combinatorial setting with AR antagonists, MAA potentiated the AR response without significantly altering the EC{sub 50} for androgen responsiveness, partially alleviating the antagonistic effect of the anti-androgens. Finally, MAA treatment of TM3 mouse testicular Leydig cells markedly increased the expression of Cyp17a1 and Shbg while suppressing Igfbp3 expression by {approx} 90%. Deregulation of these genes may alter androgen synthesis and action in a manner that contributes to MAA-induced testicular toxicity.

OSTI ID:
21272597
Journal Information:
Toxicology and Applied Pharmacology, Vol. 238, Issue 2; Other Information: DOI: 10.1016/j.taap.2008.03.015; PII: S0041-008X(08)00144-0; Copyright (c) 2008 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved; Country of input: International Atomic Energy Agency (IAEA); ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

The scaffold protein RACK1 is a target of endocrine disrupting chemicals (EDCs) with important implication in immunity
Journal Article · Thu Jun 15 00:00:00 EDT 2017 · Toxicology and Applied Pharmacology · OSTI ID:21272597

Atrazine acts as an endocrine disrupter by inhibiting cAMP-specific phosphodiesterase-4
Journal Article · Thu Nov 15 00:00:00 EST 2012 · Toxicology and Applied Pharmacology · OSTI ID:21272597

Homology-modeled ligand-binding domains of medaka estrogen receptors and androgen receptors: A model system for the study of reproduction
Journal Article · Fri Feb 27 00:00:00 EST 2009 · Biochemical and Biophysical Research Communications · OSTI ID:21272597